Xingang Bi
-
- Renal cell carcinoma treatment 15
-
- Immune cells in cancer 3
-
- Cancer Immunotherapy and Biomarkers 6
-
- Cancer Genomics and Diagnostics 3
-
- Renal and related cancers 10
-
- Bladder and Urothelial Cancer Treatments 9
- Urinary and Genital Oncology Studies 5
-
- Tuberous Sclerosis Complex Research 3
- Co-authors
- Jianzhong ShouJianhui MaBingqing ShangShan ZhengYajian LiLin FengLei GuoXi Chen
- Journals
- Journal of Clinical Oncology (5 papers)SHILAP Revista de lepidopterología (1 paper)Cancer Letters (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Xingang Bi
28 papers receiving 208 citations
Peers
Comparison fields: 5 of 47
- Pulmonary and Respiratory Medicine 85
- Immunology 48
- Oncology 61
- Cancer Research 31
- Molecular Biology 94
Countries citing papers authored by Xingang Bi
This map shows the geographic impact of Xingang Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingang Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingang Bi more than expected).
Fields of papers citing papers by Xingang Bi
This network shows the impact of papers produced by Xingang Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingang Bi. The network helps show where Xingang Bi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xingang Bi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 21 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 7 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 1 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 12 | |
| 14 | 2021 | 1 | |
| 15 | 2021 | 14 | |
| 16 | 2020 | 4 | |
| 17 | 2019 | 19 | |
| 18 | 2019 | 20 | |
| 19 | [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization]. | 2007 | 1 |
| 20 | 2005 | 14 |
About Xingang Bi
Xingang Bi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Urology, having authored 32 papers that have together received 210 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (15 papers), Renal and related cancers (10 papers), Bladder and Urothelial Cancer Treatments (9 papers), Cancer Immunotherapy and Biomarkers (6 papers), Urinary and Genital Oncology Studies (5 papers), Tuberous Sclerosis Complex Research (3 papers), Immune cells in cancer (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (85 citations), Immunology (48 citations) and Oncology (61 citations). Xingang Bi has collaborated with scholars based in China and United States. Frequent co-authors include Jianzhong Shou, Jianhui Ma, Bingqing Shang, Shan Zheng, Yajian Li, Lin Feng, Lei Guo, Xi Chen, Changling Li and Zhenhua Huang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.